#Mesothelioma Surgery (pleurectomy/decortication) worsened survival; raised likelihood of death (HR 1.28). Congrats @ekslim for leading #MAR2 to show stopping surgery will improve survival 28%. Fantastic/motivating talk! @Mesouk @atstoa @UKPleura
Socioeconomic factors can affect people’s risk of developing lung cancer. Targeted screening programmes can help remove barriers to participation by using positive messaging.
Learn more about targeted outreach in lung cancer screening. https://t.co/3mta0VpK2L
Have you watched our recent panel discussion on lung cancer screening implementation, with experts including @DRBLUNGS, @hilaryarobbins and @EbbaHallersjo? https://t.co/DrR9j3BtcQ
A lot of hard work by a lot of excellent people to get here. More work to do as we move to what, I am convinced, could be the best lung cancer screening program worldwide
https://t.co/CApTxWr8MW
Key experts in #LungCancer and #LDCT joined our webinar last week, which we hosted to showcase our implementation framework toolkit. We used this opportunity to share a deep dive into how to use our implementation framework. #LCSM
Watch the webinar here: https://t.co/DrR9j3AVni
#LungCancer screening programmes can save lives.
Our Network members have created a framework to support the implementation of #LDCT lung cancer screening and help the roll-out of screening programmes across the world. #LCSM
https://t.co/6mwrjxXQ3U
A new 12-month virtual educational initiative - The Lung Cancer Clinical Masterclass Series - is available free of charge to HCPs. In the monthly instalments two guest speakers deliver a presentation on a current topic in lung cancer.
Register to access 🔒https://t.co/h4rWi4KdzY
1/2. There has been a lot of excitement about personalized sleep medicine using phenotypes and endotypes in sleep apnea. I'm delighted to see our editorial 'Seeking Precision: Endotypes and Phenotypes of OSA' discussing recent advances and challenges. https://t.co/9hChRSwvTb
@Drziakhan125 @jp_jespark Well done @Drziakhan125 . We are building a strong foundation for nodule management. With @jp_jespark and the lung cancer team @OUHospitals
NEWS: Researchers from @OxfordOncology and the University of Nottingham have developed a new tool, called ‘CanPredict’, able to identify the people most at risk of developing lung cancer over the next 10 years.
https://t.co/elQucfQMND